ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 71 filers reported holding ALLOVIR INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,268,095 | -26.8% | 3,845,626 | +15.7% | 0.00% | – |
| Q2 2023 | $11,302,797 | +7.3% | 3,324,352 | +24.3% | 0.00% | – |
| Q1 2023 | $10,533,516 | -27.1% | 2,673,481 | -5.1% | 0.00% | – |
| Q4 2022 | $14,450,097 | -31.3% | 2,816,783 | +5.6% | 0.00% | -100.0% |
| Q3 2022 | $21,047,000 | +117.7% | 2,667,480 | +7.6% | 0.00% | – |
| Q2 2022 | $9,666,000 | -35.8% | 2,478,605 | +11.1% | 0.00% | – |
| Q1 2022 | $15,059,000 | -46.3% | 2,230,919 | +2.9% | 0.00% | -100.0% |
| Q4 2021 | $28,056,000 | -38.3% | 2,168,172 | +19.6% | 0.00% | 0.0% |
| Q3 2021 | $45,438,000 | +31.7% | 1,813,179 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $34,494,000 | -37.9% | 1,747,484 | -26.4% | 0.00% | -50.0% |
| Q1 2021 | $55,530,000 | -20.4% | 2,373,060 | +30.8% | 0.00% | 0.0% |
| Q4 2020 | $69,750,000 | +116.5% | 1,814,537 | +54.9% | 0.00% | +100.0% |
| Q3 2020 | $32,219,000 | – | 1,171,575 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |